Synthesis and characterization of neurostatin-related compounds with high inhibitory activity of glioma growth

European Journal of Medicinal Chemistry

Volumn 45, Issue 5, 2010, Pages 2034-2043

  Valle Argos, Beatriz ^a   Gómez Nicola, Diego ^a,b   Nieto Sampedro, Manuel ^a,b  

^a INSTITUTO CAJAL   (Spain)

^b National Hospital of Paraplegics (SESCAM)   (Spain)

Author keywords

CNS; Glioma; Neurostatin; O acetylation; O But GD1b; O butyrylation

Indexed keywords

2 O ACETYL GD1B; 2 O BUTYL GD1B; 3 O ACETYL GD1B; 3 O BUTYL GD1B; 4 O ACETYL GD1B; 4 O BUTYL GD1B; GANGLIOSIDE; GANGLIOSIDE GD 1B; O ACETYL GD1B; O BUTYL GD1B; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTINEOPLASTIC ACTIVITY; ARTICLE; ASTROCYTOMA CELL; CANCER INHIBITION; CELL PROLIFERATION; CONFORMATIONAL TRANSITION; CONTROLLED STUDY; DRUG ACETYLATION; DRUG PURIFICATION; DRUG STRUCTURE; DRUG SYNTHESIS; GLIOBLASTOMA; GLIOMA; HUMAN; HUMAN CELL; NONHUMAN; RAT; STRUCTURE ACTIVITY RELATION; TUMOR CELL LINE;

ANIMALS; ANTINEOPLASTIC AGENTS; CELL LINE, TUMOR; CELL PROLIFERATION; DRUG SCREENING ASSAYS, ANTITUMOR; GLIOMA; GLYCOSPHINGOLIPIDS; HUMANS; RATS; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 77949485896     PISSN: 02235234     EISSN: 17683254     Source Type: Journal    
DOI: 10.1016/j.ejmech.2010.01.015     Document Type: Article

References (21)

1. Kanu O.O., Mehta A., Di C., Lin N., Bortoff K., Bigner D.D., Yan H., and Adamson D.C. Glioblastoma multiforme: a review of therapeutic targets. Expert. Opin. Ther. Targets 13 (2009) 701-718
2. Friedman H. What is "hope" for a patient with a deadly brain tumor?. Cerebrum 5 (2003) 7-18
3. Hakomori S., and Igarashi Y. Functional role of glycosphingolipids in cell recognition and signaling. J. Biochem. 118 (1995) 1091-1103
4. Iwabuchi K., Yamamura S., Prinetti A., Handa K., and Hakomori S. GM3-enriched microdomain involved in cell adhesion and signal transduction through carbohydrate-carbohydrate interaction in mouse melanoma B16 cells. J. Biol. Chem. 273 (1998) 9130-9138
5. Miljan E.A., Meuillet E.J., Mania-Farnell B., George D., Yamamoto H., Simon H.G., and Bremer E.G. Interaction of the extracellular domain of the epidermal growth factor receptor with gangliosides. J. Biol. Chem. 277 (2002) 10108-10113
6. Hakomori S., Yamamura S., and Handa A.K. Signal transduction through glyco(sphingo)lipids. Introduction and recent studies on glyco(sphingo)lipid-enriched microdomains. Ann. N.Y. Acad. Sci. 845 (1998) 1-10
7. Zervas M., and Walkley S.U. Ferret pyramidal cell dendritogenesis: changes in morphology and ganglioside expression during cortical development. J. Comp. Neurol. 413 (1999) 429-448
8. Varki A. Diversity in the sialic acids. Glycobiology 2 (1992) 25-40
9. Furuhata K. Chemistry of N-acetylneuraminic acid (Neu5Ac). Trends Glycosci. Glycotechnol. 16 (2004) 146-169
10. Abad-Rodriguez J., Vallejo-Cremades M., and Nieto-Sampedro M. Control of glial number: purification from mammalian brain extracts of an inhibitor of astrocyte division. Glia 23 (1998) 156-168
11. Abad-Rodriguez J., Bernabe M., Romero-Ramirez L., Vallejo-Cremades M., Fernandez-Mayoralas A., and Nieto-Sampedro M. Purification and structure of neurostatin, an inhibitor of astrocyte division of mammalian brain. J. Neurochem. 74 (2000) 2547-2556
12. Romero-Ramirez L., and Nieto-Sampedro M. Inhibiting human astrocytoma growth: structure-activity relationships in neurostatin related glycolipids. J. Med. Chem. 47 (2004) 4983-4984
13. Hubl U., Ishida H., Kiso M., Hasegawa A., and Schauer R. Studies on the specificity and sensitivity of the influenza C virus binding assay for 9-O-acetylated sialic acids and its application to human melanomas. J. Biochem. 127 (2000) 1021-1031
14. Santos-Benito F.F., Fernandez-Mayoralas A., Martin-Lomas M., and Nieto-Sampedro M. Inhibition of proliferation of normal and transformed neural cells by blood group-related oligosaccharides. J. Exp. Med. 176 (1992) 915-918
15. Nieto-Sampedro M., Bailon C., Fernandez-Mayoralas A., Martin-Lomas M., Mellstrom B., and Naranjo J.R. Experimental brain glioma: growth arrest and destruction by a blood-group-related tetrasaccharide. J. Neuropathol. Exp. Neurol. 55 (1996) 169-177
16. Gomez-Nicola D., Valle-Argos B., Suardiaz M., Taylor J.S., and Nieto-Sampedro M. Role of IL-15 in spinal cord and sciatic nerve after chronic constriction injury: regulation of macrophage and T-cell infiltration. J. Neurochem. 107 (2008) 1741-1752
17. Gomez-Nicola D., Valle-Argos B., and Nieto-Sampedro M. Blockade of IL-15 activity inhibits microglial activation through the NFkappaB, p38, and ERK1/2 pathways, reducing cytokine and chemokine release. Glia 58 (2010) 264-276
18. Ogura H., Furuhata K., Sato S., Anazawa K., Itoh M., and Shitori Y. Synthesis of 9-O-acyl- and 4-O-acetyl-sialic acids. Carbohydr. Res. 167 (1987) 77-86
19. Williams M.A., and McCluer R.H. The use of Sep-Pak C18 cartridges during the isolation of gangliosides. J. Neurochem. 35 (1980) 266-269
20. Kanzawa T., Germano I.M., Kondo Y., Ito H., Kyo S., and Kondo S. Inhibition of telomerase activity in malignant glioma cells correlates with their sensitivity to temozolomide. Br. J. Cancer 89 (2003) 922-929
21. Stevens M.F., Hickman J.A., Langdon S.P., Chubb D., Vickers L., Stone R., Baig G., Goddard C., Gibson N.W., Slack J.A., Newton C., Lunt E., Fizames C., and Lavelle F. Antitumor activity and pharmacokinetics in mice of 8-carbamoyl-3-methyl-imidazo[5,1-d]-1,2,3,5-tetrazin-4(3H)-one (CCRG 81045; M & B 39831), a novel drug with potential as an alternative to dacarbazine. Cancer Res. 47 (1987) 5846-5852